The limitations of model systems in prostatic cancer

Oncology
|January 1, 1977
PubMed

Insights

No single model can guide all treatment strategies or biological insights. Multiple models are necessary, but direct clinical research in humans is often sufficient with current treatments.

Area of Science:

  • Biomedical Research
  • Translational Science

Background:

  • Developing ideal preclinical models for all research questions is unrealistic.
  • A diverse range of models is needed to address various scientific inquiries.

Purpose of the Study:

  • To evaluate the necessity and utility of preclinical models in the context of current treatment modalities.
  • To discuss the limitations of seeking a singular ideal model for biological insights and treatment design.

Main Methods:

  • Literature review and conceptual analysis of preclinical model utility.
  • Discussion of the role of direct human studies in medical research.

Main Results:

  • The pursuit of a universal preclinical model is deemed impractical.
  • Existing treatment options allow for significant direct research in human subjects.

Conclusions:

  • A multifaceted approach utilizing various models is essential for comprehensive biological understanding.
  • Direct clinical investigation in humans is a viable and often sufficient strategy, reducing reliance on preclinical models for certain research aims.